Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +117.81%
#2 Lisk Lisk +81.56%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +30.37%
#4 Tokenlon Tokenlon +28.92%
#5 Alchemist AI Alchemist AI +28.02%
#6 Nockchain Nockchain +25.68%
#7 earnAUSD earnAUSD +24.75%
#8 Renzo Renzo +21.89%
#9 Illuvium Illuvium +19.74%
#10 Akedo Akedo +18.38%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Kedudukan dalam Saham #41009
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm,... MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges, including neurological conditions, liver ailments, various types of cancer, and applications within interventional cardiology and peripheral vascular health. The company's product pipeline features several key developments: MCT-125: This investigational therapy is currently in Phase II clinical trials, targeting the primary fatigue commonly associated with multiple sclerosis. MCT-465: A preclinical-stage synthetic double-stranded RNA (dsRNA) candidate, designed to act as a powerful immune enhancer for the treatment of solid tumor malignancies. MCT-485: Another dsRNA therapeutic, still in the discovery phase, which demonstrates tumor cytolytic (cell-destroying) properties, intended for use against diverse cancers. Beyond drug candidates, MultiCell Technologies is also progressing the Ideal BioStent, an innovative bioabsorbable stent specifically engineered for use in interventional cardiology and peripheral vessel procedures. The organization maintains licensing agreements with prominent entities such as Corning Incorporated and Pfizer Inc. Established in 1962, the company was previously known as Exten Industries, Inc. before officially changing its name to MultiCell Technologies, Inc. in April 2004. Its corporate headquarters are situated in Woonsocket, Rhode Island.
Harga Saham
$0.00001
Disegerakkan terakhir: 2026-09-10
Modal Pasaran
$50.01K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan MultiCell Technologies, Inc. (MCET)

Kategori

Healthcare
Bilangan saham terbitan bagi MultiCell Technologies, Inc. (MCET)
Bilangan saham terbitan setakat August 2015: 5.14M
Menurut laporan kewangan terkini dan harga saham MultiCell Technologies, Inc., bilangan saham terbitan semasa ialah 5.14M. Pada akhir November 2013, syarikat mempunyai 1.92M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk MultiCell Technologies, Inc. (MCET) dari 2013 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 5.14M 37.91%
2014 3.73M 94.37%
2013 1.92M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 4,840.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,110.15%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 7,606.31%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 9,219.81%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH